Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Shafrin

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Health Affairs (Project Hope)|April 8, 2015
Quality-adjusted cost of care: a meaningful way to measure growth in innovation cost versus the value of health gainsDarius Lakdawalla, Jason Shafrin, Claudio Lucarelli, et al.
The American Journal of Managed Care|July 12, 2024
Quantifying the insurance value for rare diseases: Duchenne muscular dystrophyJason Shafrin, Suhail Thahir, Alexa C Klimchak, et al.
Journal of Managed Care & Specialty Pharmacy|July 31, 2025
A structured approach for identifying disease analogs for pulmonary arterial hypertensionKarim El-Kersh, Nadine Zawadzki, Anna Watzker, et al.
The American Journal of Managed Care|May 19, 2025
Quantifying the altruism value for a rare pediatric disease: Duchenne muscular dystrophyJason Shafrin, Suhail Thahir, Alexa C Klimchak, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 2, 2017
Value-Based Payments and Incentives to Improve Care: A Case Study of Patients with Type 2 Diabetes in Medicare AdvantageJesse Sussell, Kata Bognar, Taylor T Schwartz, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 31, 2023
Use of Conditionally Essential Amino Acids and the Economic Burden of Postoperative Complications After Fracture Fixation: Results from a Cost Utility AnalysisJason Shafrin, Kyi-Sin Than, Anmol Kanotra, et al.
Current Medical Research and Opinion|January 9, 2016
The value of surrogate endpoints for predicting real-world survival across five cancer typesJason Shafrin, Ron Brookmeyer, Desi Peneva, et al.
P & T : a Peer-Reviewed Journal for Formulary Management|June 5, 2019
Using Information on Patient Adherence to Antipsychotic Medication to Understand Their Adherence to Other MedicationsJason Shafrin, Alison R Silverstein, Joanna P MacEwan, et al.
Advances in Therapy|May 5, 2018
Medication Adherence Patterns Among Patients with Multiple Serious Mental and Physical IllnessesJoanna P MacEwan, Alison R Silverstein, Jason Shafrin, et al.
Clinical Lung Cancer|September 5, 2025
Imaging Utilization and Treatment Patterns of Brain Metastases in Patients With Non-Small Cell Lung Cancer: A SEER-Medicare and SEER Database AnalysisMark D Danese, Jason Shafrin, Melissa Laurie, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Health Affairs (Project Hope)|April 8, 2015
Quality-adjusted cost of care: a meaningful way to measure growth in innovation cost versus the value of health gainsDarius Lakdawalla, Jason Shafrin, Claudio Lucarelli, et al.
The American Journal of Managed Care|July 12, 2024
Quantifying the insurance value for rare diseases: Duchenne muscular dystrophyJason Shafrin, Suhail Thahir, Alexa C Klimchak, et al.
Journal of Managed Care & Specialty Pharmacy|July 31, 2025
A structured approach for identifying disease analogs for pulmonary arterial hypertensionKarim El-Kersh, Nadine Zawadzki, Anna Watzker, et al.
The American Journal of Managed Care|May 19, 2025
Quantifying the altruism value for a rare pediatric disease: Duchenne muscular dystrophyJason Shafrin, Suhail Thahir, Alexa C Klimchak, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 2, 2017
Value-Based Payments and Incentives to Improve Care: A Case Study of Patients with Type 2 Diabetes in Medicare AdvantageJesse Sussell, Kata Bognar, Taylor T Schwartz, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 31, 2023
Use of Conditionally Essential Amino Acids and the Economic Burden of Postoperative Complications After Fracture Fixation: Results from a Cost Utility AnalysisJason Shafrin, Kyi-Sin Than, Anmol Kanotra, et al.
Current Medical Research and Opinion|January 9, 2016
The value of surrogate endpoints for predicting real-world survival across five cancer typesJason Shafrin, Ron Brookmeyer, Desi Peneva, et al.
P & T : a Peer-Reviewed Journal for Formulary Management|June 5, 2019
Using Information on Patient Adherence to Antipsychotic Medication to Understand Their Adherence to Other MedicationsJason Shafrin, Alison R Silverstein, Joanna P MacEwan, et al.
Advances in Therapy|May 5, 2018
Medication Adherence Patterns Among Patients with Multiple Serious Mental and Physical IllnessesJoanna P MacEwan, Alison R Silverstein, Jason Shafrin, et al.
Clinical Lung Cancer|September 5, 2025
Imaging Utilization and Treatment Patterns of Brain Metastases in Patients With Non-Small Cell Lung Cancer: A SEER-Medicare and SEER Database AnalysisMark D Danese, Jason Shafrin, Melissa Laurie, et al.
Pageof 9